Rise and shine. Another day is on the way. As always, this will be a busy one, as we scramble once again to get caught up on our reading and phone calls. Sound familiar? Of course. So please join us as we fortify ourselves with a delicious cup of stimulation - we are back to Southern Pecan - and dig in. And to help you along, we have gathered another bushel of interesting tidbits. Hope you accomplish much today and drop us a line if you hear anything interesting...
IUDs And Implants Last Longer Than Birth Control Pills (Reuters)
Canada Should Boost Clinical Trial Funding (Regulatory Focus)
PPD Hires Pfizer Exec Simmons As CEO (Wilmington Business Journal)
Teva Cuts Its Outlook For 2012 (Reuters)
Drugmakers Study Patient Recruiting In Emerging Markets (Outsourcing Pharma)
Pfizer Launches Mobile App For Lipitor (Marketing Daily)
Germanys' Reimser Is A Takeover Target (Bloomberg News)
Novo Nordisk Diabetes Drug Is Approved For Toddlers (MedCity News)
Shanghai Pharma Denies Financial Fraud Probe (Bloomberg News)
Glaxo Sifts Through Collaborations For Acquisitions (Bloomberg News)
After Successful IPO, Versatem Tries To Deliver On Promise (Boston Globe)
EDITOR'S NOTE: Please check this for updates during the day
2 Comments
To be safe, as always, check withn your undertaker.